Oryzon Genomics SA
MAD:ORY

Watchlist Manager
Oryzon Genomics SA Logo
Oryzon Genomics SA
MAD:ORY
Watchlist
Price: 1.516 EUR -1.17%
Market Cap: 96.7m EUR
Have any thoughts about
Oryzon Genomics SA?
Write Note

Income Statement

Earnings Waterfall
Oryzon Genomics SA

Revenue
0 EUR
Cost of Revenue
-1.2m EUR
Gross Profit
-1.2m EUR
Operating Expenses
-3.5m EUR
Operating Income
-4.7m EUR
Other Expenses
712.4k EUR
Net Income
-4m EUR

Income Statement
Oryzon Genomics SA

Rotate your device to view
Income Statement
Currency: EUR
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
(4)
(4)
(3)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
Gross Profit
(4)
N/A
(4)
-5%
(3)
+15%
(2)
+27%
(2)
+8%
(2)
+21%
(1)
+19%
(1)
+18%
(1)
+29%
(1)
-33%
(1)
-16%
Operating Income
Operating Expenses
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
Selling, General & Administrative
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
Depreciation & Amortization
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
Operating Income
(7)
N/A
(7)
-2%
(6)
+12%
(5)
+11%
(5)
+6%
(5)
+10%
(5)
-2%
(5)
+4%
(4)
+6%
(4)
-4%
(5)
-5%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(1)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
Non-Reccuring Items
0
(0)
(0)
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(7)
N/A
(7)
-2%
(6)
+11%
(7)
-4%
(7)
-1%
(6)
+4%
(7)
-4%
(6)
+9%
(6)
+7%
(6)
-2%
(6)
-3%
Net Income
Tax Provision
2
2
2
2
2
3
3
3
3
2
2
Income from Continuing Operations
(5)
(5)
(4)
(4)
(4)
(4)
(4)
(3)
(3)
(4)
(4)
Net Income (Common)
(5)
N/A
(5)
-10%
(4)
+19%
(4)
-5%
(4)
+0%
(4)
+17%
(4)
-12%
(3)
+15%
(3)
+14%
(4)
-33%
(4)
-4%
EPS (Diluted)
-0.09
N/A
-0.09
N/A
-0.08
+11%
-0.08
N/A
-0.07
+13%
-0.06
+14%
-0.07
-17%
-0.06
+14%
-0.04
+33%
-0.06
-50%
-0.06
N/A

See Also

Discover More